Abbott Laboratories | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,576
2,284
4,423
1,400
477
2,368
Depreciation, Depletion & Amortization
1,719
1,548
1,472
1,353
3,021
3,278
Other Funds
6,396
400
17
195
13
802
Funds from Operations
4,561
4,165
3,122
4,741
4,818
6,448
Changes in Working Capital
1,237
490
156
1,513
1,915
148
Net Operating Cash Flow
3,324
3,675
2,966
3,203
5,570
6,300
Capital Expenditures
1,145
1,077
1,110
1,121
1,135
Sale of Fixed Assets & Businesses
-
5
230
25
6,042
Purchase/Sale of Investments
2,225
4,117
1,469
886
2,623
Net Investing Cash Flow
3,929
202
406
248
9,618
Cash Dividends Paid - Total
882
1,342
1,443
1,539
1,849
Issuance/Reduction of Debt, Net
1,792
766
1,147
13,155
2,942
Net Financing Cash Flow
6,696
2,742
2,236
11,147
5,281
Net Change in Cash
7,327
588
938
13,619
9,213
Free Cash Flow
2,179
2,598
1,856
2,082
4,435
Net Assets from Acquisitions
580
3,317
235
80
17,183
Other Sources
21
70
52
42
35
Change in Capital Stock
1,210
1,766
1,923
274
477
Exchange Rate Effect
26
143
198
483
116
Extraordinaries
-
-
-
25
1,163
-
About Abbott Laboratories
View Profile
